Activation of mTOR contributes to tumor cell survival in ALK (anaplastic lymphoma kinase)-positive ALCL (anaplastic large cell lymphoma) [102], mantle cell lymphoma [103], childhood B-precursor ALL [112], T-ALL [110], and AML [291]. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.